Relmada Therapeutics, Inc. (RLMD)
3.58
+0.14
(+4.07%)
USD |
NASDAQ |
Oct 30, 16:00
3.595
+0.02
(+0.42%)
After-Hours: 20:00
Relmada Therapeutics Market Cap : 381.88M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 381.88M |
| October 29, 2026 | 366.94M |
| October 28, 2026 | 357.34M |
| October 27, 2026 | 342.41M |
| October 26, 2026 | 344.54M |
| October 23, 2026 | 348.81M |
| October 22, 2026 | 350.94M |
| October 21, 2026 | 342.41M |
| October 20, 2026 | 358.41M |
| October 19, 2026 | 337.08M |
| October 16, 2026 | 330.68M |
| October 15, 2026 | 341.34M |
| October 14, 2026 | 345.61M |
| October 13, 2026 | 358.41M |
| October 12, 2026 | 374.41M |
| October 09, 2026 | 361.61M |
| October 08, 2026 | 338.14M |
| October 07, 2026 | 346.68M |
| October 06, 2026 | 349.88M |
| October 05, 2026 | 371.21M |
| October 02, 2026 | 384.01M |
| October 01, 2026 | 390.41M |
| September 30, 2026 | 402.15M |
| September 29, 2026 | 397.88M |
| September 28, 2026 | 404.28M |
| Date | Value |
|---|---|
| September 25, 2026 | 408.55M |
| September 24, 2026 | 406.41M |
| September 23, 2026 | 403.21M |
| September 22, 2026 | 452.28M |
| September 21, 2026 | 443.75M |
| September 18, 2026 | 439.48M |
| September 17, 2026 | 448.01M |
| September 16, 2026 | 450.15M |
| September 15, 2026 | 473.61M |
| September 14, 2026 | 473.61M |
| September 11, 2026 | 482.15M |
| September 10, 2026 | 434.15M |
| September 09, 2026 | 436.28M |
| September 08, 2026 | 453.35M |
| September 04, 2026 | 472.55M |
| September 03, 2026 | 466.15M |
| September 02, 2026 | 484.28M |
| September 01, 2026 | 475.75M |
| August 31, 2026 | 465.08M |
| August 28, 2026 | 461.88M |
| August 27, 2026 | 482.15M |
| August 26, 2026 | 485.35M |
| August 25, 2026 | 489.61M |
| August 24, 2026 | 488.55M |
| August 21, 2026 | 493.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.654B |
| Corcept Therapeutics, Inc. | 8.755B |
| Veru, Inc. | 37.34M |
| Johnson & Johnson | 657.62B |
| Eli Lilly & Co. | 1.334T |
Market Cap Related Metrics
| Price to Book Value | 1.849 |
| Price | 3.58 |
| Earnings Yield | -25.98% |